Monaghan Medical Corporation Receives Zenith Award from American Association of Respiratory Care for Sixth Consecutive Year
November 24, 2020 15:27 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (Monaghan Medical) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the...
Monaghan Medical Corporation Opens New State-of-the-Art Manufacturing Facility in Plattsburgh, New York
November 05, 2020 08:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) today announced the opening of a new 65,000-square-foot facility that doubles the size of its previous...
Monaghan Medical Corporation Announces FDA Clearance for New Respiratory Treatment Option
January 07, 2020 08:40 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) today announced the newly approved combination for two of its groundbreaking products—the Aerobika®...
Monaghan Medical Corporation Wins Prestigious Zenith Award from the American Association of Respiratory Care
November 12, 2019 08:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth...
Monaghan Medical Corporation Introduces an Intermediate-Size Mask
June 05, 2019 08:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., June 05, 2019 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) today introduced new product enhancements to continue their mission to ensure device quality for patients....
Significant reductions in costly pulmonary complications with use of drug-free device
June 20, 2018 07:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., June 20, 2018 (GLOBE NEWSWIRE) -- Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in Pulmonary...
New published evidence reinforces the importance of device choice in asthma control
January 31, 2018 08:45 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Jan. 31, 2018 (GLOBE NEWSWIRE) -- A recent article in Pulmonary Pharmacology and Physiology1 provides in vitro evidence that the AEROCHAMBER PLUS® FLOW-VU® valved holding chamber...
Landmark asthma study demonstrates device choice determines asthma control
November 30, 2017 08:45 ET
|
Monaghan Medical Corporation
NEW YORK, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an...